Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Pain, Postoperative 1Pain 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Narcotics × Clear all
NCT03393117 2020-07-22

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT02044302 2017-04-10

A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

Yale University

Phase 2 Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡